Login
$VRTX
$543.99 +$5.39 (1.0%) Live

Ownership

13F as of Q2 2026 · 253.5M shares outstanding

Who owns VRTX?

By type of holder
Institutions 95.1% Insiders 0.2% Everyone else 4.7%
Concentration Top 10 holders own 50.6%
Capital World Investors 10.3% · BlackRock, Inc. 9.5%
Institutional ownership
95.1%
+1.3 pts vs last qtr
Institutional holders
1,748
+57 vs last qtr
Net shares bought
+3.4M
by institutions in Q2 2026
New / sold out
194 / 137
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Norges Bank NEW +3.0M
  • Franklin Resources Inc +2.8M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Janus Henderson Group PLC SOLD OUT −2.1M
  • Capital Research Global Investors −1.6M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$131M
54 notices from 13 people
Shares covered
280.7K
0.11% of the company
Arranged in advance
98%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$31.2M$62.5MDec 2025: $36.2M under a 10b5-1 planDecJan 2026: $6.5M under a 10b5-1 planJanFeb 2026: $62.5M under a 10b5-1 planFebMar 2026: $5.1M under a 10b5-1 planMarApr 2026: $439.3K under a 10b5-1 planAprMay 2026: $5.3M under a 10b5-1 planMay 2026: $2.2M without a planMayJun 2026: $3.7M under a 10b5-1 planJunJul 2026: $2.0M under a 10b5-1 planJulAug 2026: $662.5K without a planAugSepOctNov 2026: $6.3M under a 10b5-1 planNov
Largest proposed sellers
  • Sachdev Amit Officer 10b5-1 $28.4M
  • Jeffrey M Leiden Director 10b5-1 $27.6M

Sign up to see all 5.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
+5.4%
+0.59% a year
Each share's claim on the business
−5.2%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
$6.12B vs $4.55B
over 10 fiscal years
Diluted shares, split-adjusted
237.3M251.7M266.0M2016: 244.7M shares'162017: 253.2M shares'172018: 259.2M shares'182019: 260.7M shares'192020: 263.4M shares'202021: 259.9M shares'212022: 259.1M shares'222023: 260.5M shares'232024: 257.9M shares'242025: 258.0M shares'25
Buybacks Stock-based comp
$0$1.01B$2.02B2016 buybacks: $02016 stock comp: $240.6M'162017 buybacks: $02017 stock comp: $293.2M'172018 buybacks: $350.0M2018 stock comp: $325.0M'182019 buybacks: $186.0M2019 stock comp: $360.5M'192020 buybacks: $539.1M2020 stock comp: $429.5M'202021 buybacks: $1.43B2021 stock comp: $441.4M'212022 buybacks: $02022 stock comp: $491.3M'222023 buybacks: $427.6M2023 stock comp: $581.2M'232024 buybacks: $1.18B2024 stock comp: $698.5M'242025 buybacks: $2.02B2025 stock comp: $685.9M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years80% 3–5 years10% 1–3 years6% Under 1 year4%
Quarterly turnover
6.0%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting VRTX on Form 13F
CW
Capital World Investors
Shares
26.1M
% of company
10.30%
Change vs last qtr
+746.9K (+2.9%)
Held since
≤2021
B
BlackRock, Inc.
Shares
24.1M
% of company
9.51%
Change vs last qtr
+139.9K (+0.6%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding VERTEX PHARMACEUTICALS INC / MA, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting VRTX on Form N-PORT; together they hold 50.8% of the company
GF
Growth Fund of America
Position value
$7.03B
% of company
5.09%
% of the fund
1.99%
As of
August 31, 2026
VT
Position value
$4B
% of company
3.18%
% of the fund
0.17%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding VERTEX PHARMACEUTICALS INC / MA and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
SA
Sachdev Amit
Insider
Shares
96.3K
% of company
0.04%
Change vs last qtr
—
Held since
—
KR
Kewalramani Reshma
Insider
Shares
86.5K
% of company
0.03%
Change vs last qtr
—
Held since
—

22 more holders behind a free account

See every insider and 5%+ holder of VERTEX PHARMACEUTICALS INC / MA.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support